DEVELOPMENT OF CELLULAR AND GENETIC TECHNOLOGIES IN RUSSIA
Effective Healthcare
January 15, 2020, 11:30 – 13:30, Building 5, Floor 5, Conference Hall
Share
The world is rapidly developing genetic, cellular and genomic technologies in healthcare, including the rigorous introduction of gene therapy and cellular drugs into clinical practice to target the cause of the disease. The emergence of this class of drugs has made it possible to effectively combat diseases that used to be incurable.
The introduction and application of innovative gene therapy and cell technologies in Russia is difficult for a number of reasons: a complicated registration process, patients' limited access to genetic diagnostic methods, and an imperfect medical care payment system. Successful implementation of innovative technologies is possible only with an intensive dialogue between the state and the manufacturers in order to adapt legal regulation and ensure better availability of such technologies for patients.
Issues for Discussion
Biomedical cell products and high-tech medicines: harmonization of concepts within a single pharmaceutical market framework.
Providing government funding to use gene technologies in the healthcare system.
Deputy Director General, Director of the Higher School of Molecular and Experimental Medicine, Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology
Deputy Director General, Federal State Budgetary Institution “Scientific Center for Expert Evaluation of Medicinal Products”, Ministry of Health of the Russian Federation
Head of the Division of Work Coordination in the Sphere of Medicines and Medical Devices Circulation, Technical Regulation and Accreditation Department of the Eurasian Economic Commission
Director General, Federal State Budgetary Institution National Medical Research Center named after V.A. Almazov, Ministry of Health of the Russian Federation
President, All-Russian Charitable Public Organization of Disabled People “Russian Hemophilia Society”
Array
(
[ACTIVE_TO] => 01/15/2020 01:30:00 pm
[~ACTIVE_TO] => 01/15/2020 01:30:00 pm
[ACTIVE_FROM] => 01/15/2020 11:30:00 am
[~ACTIVE_FROM] => 01/15/2020 11:30:00 am
[ID] => 21659
[~ID] => 21659
[NAME] => DEVELOPMENT OF CELLULAR AND GENETIC TECHNOLOGIES IN RUSSIA
[~NAME] => DEVELOPMENT OF CELLULAR AND GENETIC TECHNOLOGIES IN RUSSIA
[IBLOCK_ID] => 18
[~IBLOCK_ID] => 18
[IBLOCK_SECTION_ID] => 378
[~IBLOCK_SECTION_ID] => 378
[DETAIL_TEXT] =>
[~DETAIL_TEXT] =>
[DETAIL_TEXT_TYPE] => html
[~DETAIL_TEXT_TYPE] => html
[PREVIEW_TEXT] =>
The world is rapidly developing genetic, cellular and genomic technologies in healthcare, including the rigorous introduction of gene therapy and cellular drugs into clinical practice to target the cause of the disease. The emergence of this class of drugs has made it possible to effectively combat diseases that used to be incurable.
The introduction and application of innovative gene therapy and cell technologies in Russia is difficult for a number of reasons: a complicated registration process, patients' limited access to genetic diagnostic methods, and an imperfect medical care payment system. Successful implementation of innovative technologies is possible only with an intensive dialogue between the state and the manufacturers in order to adapt legal regulation and ensure better availability of such technologies for patients.
[~PREVIEW_TEXT] =>
The world is rapidly developing genetic, cellular and genomic technologies in healthcare, including the rigorous introduction of gene therapy and cellular drugs into clinical practice to target the cause of the disease. The emergence of this class of drugs has made it possible to effectively combat diseases that used to be incurable.
The introduction and application of innovative gene therapy and cell technologies in Russia is difficult for a number of reasons: a complicated registration process, patients' limited access to genetic diagnostic methods, and an imperfect medical care payment system. Successful implementation of innovative technologies is possible only with an intensive dialogue between the state and the manufacturers in order to adapt legal regulation and ensure better availability of such technologies for patients.
[PREVIEW_TEXT_TYPE] => html
[~PREVIEW_TEXT_TYPE] => html
[DETAIL_PICTURE] =>
[~DETAIL_PICTURE] =>
[TIMESTAMP_X] => 01/21/2020 03:33:13 pm
[~TIMESTAMP_X] => 01/21/2020 03:33:13 pm
[LIST_PAGE_URL] => /program/
[~LIST_PAGE_URL] => /program/
[DETAIL_PAGE_URL] => /program/15-january/development-of-cellular-and-genetic-technologies-in-russia/
[~DETAIL_PAGE_URL] => /program/15-january/development-of-cellular-and-genetic-technologies-in-russia/
[LANG_DIR] => /
[~LANG_DIR] => /
[CODE] => development-of-cellular-and-genetic-technologies-in-russia
[~CODE] => development-of-cellular-and-genetic-technologies-in-russia
[EXTERNAL_ID] => 21659
[~EXTERNAL_ID] => 21659
[IBLOCK_TYPE_ID] => content
[~IBLOCK_TYPE_ID] => content
[IBLOCK_CODE] => program
[~IBLOCK_CODE] => program
[IBLOCK_EXTERNAL_ID] => 900
[~IBLOCK_EXTERNAL_ID] => 900
[LID] => en
[~LID] => en
[NAV_RESULT] =>
[DISPLAY_ACTIVE_FROM] => 15 January 2020
[IPROPERTY_VALUES] => Array
(
)
[FIELDS] => Array
(
[ACTIVE_TO] => 01/15/2020 01:30:00 pm
[ACTIVE_FROM] => 01/15/2020 11:30:00 am
)
[PROPERTIES] => Array
(
[QUESTIONS] => Array
(
[ID] => 50
[TIMESTAMP_X] => 2017-12-20 14:14:00
[IBLOCK_ID] => 18
[NAME] => Вопросы для обсуждения
[ACTIVE] => Y
[SORT] => 10
[CODE] => QUESTIONS
[DEFAULT_VALUE] => Array
(
[TYPE] => HTML
[TEXT] =>
)
[PROPERTY_TYPE] => S
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => N
[XML_ID] => 12
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 0
[WITH_DESCRIPTION] => Y
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] => HTML
[USER_TYPE_SETTINGS] => Array
(
[height] => 200
)
[HINT] =>
[PROPERTY_VALUE_ID] => 120621
[VALUE] => Array
(
[TEXT] => <p>
</p>
<ul class="style-prog-list">
<li>Biomedical cell products and high-tech medicines: harmonization of concepts within a single pharmaceutical market framework. </li>
<li>
Providing government funding to use gene technologies in the healthcare system.</li>
</ul>
[TYPE] => HTML
)
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] => Array
(
[TEXT] =>
Biomedical cell products and high-tech medicines: harmonization of concepts within a single pharmaceutical market framework.
Providing government funding to use gene technologies in the healthcare system.
[TYPE] => HTML
)
[~DESCRIPTION] =>
[~NAME] => Вопросы для обсуждения
[~DEFAULT_VALUE] => Array
(
[TYPE] => HTML
[TEXT] =>
)
)
[TYPE] => Array
(
[ID] => 51
[TIMESTAMP_X] => 2017-12-20 14:14:00
[IBLOCK_ID] => 18
[NAME] => Тип мероприятия
[ACTIVE] => Y
[SORT] => 20
[CODE] => TYPE
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => L
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => N
[XML_ID] => 13
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 0
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] => 139653
[VALUE] => Expert Discussion
[DESCRIPTION] =>
[VALUE_ENUM] => Expert Discussion
[VALUE_XML_ID] => 2
[VALUE_SORT] => 200
[VALUE_ENUM_ID] => 7
[~VALUE] => Expert Discussion
[~DESCRIPTION] =>
[~NAME] => Тип мероприятия
[~DEFAULT_VALUE] =>
)
[LOCATION] => Array
(
[ID] => 54
[TIMESTAMP_X] => 2017-12-20 14:14:00
[IBLOCK_ID] => 18
[NAME] => Место проведения мероприятия
[ACTIVE] => Y
[SORT] => 30
[CODE] => LOCATION
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => S
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => N
[XML_ID] => 19
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 0
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] => 120625
[VALUE] => Building 5, Floor 5, Conference Hall
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] => Building 5, Floor 5, Conference Hall
[~DESCRIPTION] =>
[~NAME] => Место проведения мероприятия
[~DEFAULT_VALUE] =>
)
[MODERATORS] => Array
(
[ID] => 52
[TIMESTAMP_X] => 2017-12-20 14:15:56
[IBLOCK_ID] => 18
[NAME] => Модераторы
[ACTIVE] => Y
[SORT] => 40
[CODE] => MODERATORS
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => E
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => Y
[XML_ID] => 14
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 17
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] => Array
(
[0] => 120623
)
[VALUE] => Array
(
[0] => Array
(
[ID] => 1879
[NAME] => Vitaly Omelyanovsky
[DETAIL_PAGE_URL] => /experts/vitaly-omelyanovsky/
[POSITION] => Director General of the Center of Healthcare Expert Evaluation and Quality Control, Ministry of Health of the Russian Federation
[DONOTLINK] =>
[PREVIEW_PICTURE] => 37032
)
)
[DESCRIPTION] => Array
(
[0] =>
)
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] => Array
(
[0] => 1879
)
[~DESCRIPTION] => Array
(
[0] =>
)
[~NAME] => Модераторы
[~DEFAULT_VALUE] =>
)
[KEYREPORTS] => Array
(
[ID] => 68
[TIMESTAMP_X] => 2017-12-20 14:15:25
[IBLOCK_ID] => 18
[NAME] => Ключевой доклад
[ACTIVE] => Y
[SORT] => 50
[CODE] => KEYREPORTS
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => E
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => Y
[XML_ID] =>
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 17
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Ключевой доклад
[~DEFAULT_VALUE] =>
)
[PARTICIPANTS] => Array
(
[ID] => 53
[TIMESTAMP_X] => 2017-12-20 14:16:15
[IBLOCK_ID] => 18
[NAME] => Экперты
[ACTIVE] => Y
[SORT] => 60
[CODE] => PARTICIPANTS
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => E
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => Y
[XML_ID] => 15
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 17
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] => Array
(
[0] => 124691
[1] => 124713
[2] => 124714
[3] => 124716
[4] => 124725
[5] => 124726
[6] => 126865
[7] => 126866
[8] => 126867
[9] => 126869
[10] => 129405
)
[VALUE] => Array
(
[0] => Array
(
[ID] => 21853
[NAME] => Vadim Govorun
[DETAIL_PAGE_URL] => /experts/vadim-govorun/
[POSITION] => Director General, Federal Scientific and Clinical Center of Physical-Chemical Medicine, FMBA of Russia
[DONOTLINK] =>
[PREVIEW_PICTURE] =>
)
[1] => Array
(
[ID] => 21854
[NAME] => Etienne Jousseaume
[DETAIL_PAGE_URL] => /experts/etienne-jousseaume/
[POSITION] => Head of Market Access, Cell and Gene Europe, Novartis Pharma LLC
[DONOTLINK] =>
[PREVIEW_PICTURE] =>
)
[2] => Array
(
[ID] => 21851
[NAME] => Igor Korobko
[DETAIL_PAGE_URL] => /experts/igor-korobko/
[POSITION] => Director of the Department of Science, Innovative Development, and Biomedical Health Risks Management, Ministry of Health of the Russian Federation
[DONOTLINK] =>
[PREVIEW_PICTURE] =>
)
[3] => Array
(
[ID] => 21856
[NAME] => Mikhail Maschan
[DETAIL_PAGE_URL] => /experts/mikhail-maschan/
[POSITION] => Deputy Director General, Director of the Higher School of Molecular and Experimental Medicine, Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology
[DONOTLINK] =>
[PREVIEW_PICTURE] =>
)
[4] => Array
(
[ID] => 21858
[NAME] => Vadim Merkulov
[DETAIL_PAGE_URL] => /experts/vadim-merkulov/
[POSITION] => Deputy Director General, Federal State Budgetary Institution “Scientific Center for Expert Evaluation of Medicinal Products”, Ministry of Health of the Russian Federation
[DONOTLINK] =>
[PREVIEW_PICTURE] =>
)
[5] => Array
(
[ID] => 21860
[NAME] => Sissel Rodahl
[DETAIL_PAGE_URL] => /experts/sissel-rodahl/
[POSITION] => Director General for Cenral Europe Countries & Russia, AveXis
[DONOTLINK] =>
[PREVIEW_PICTURE] =>
)
[6] => Array
(
[ID] => 21861
[NAME] => Dmitry Rozhdestvensky
[DETAIL_PAGE_URL] => /experts/dmitry-rozhdestvensky/
[POSITION] => Head of the Division of Work Coordination in the Sphere of Medicines and Medical Devices Circulation, Technical Regulation and Accreditation Department of the Eurasian Economic Commission
[DONOTLINK] =>
[PREVIEW_PICTURE] =>
)
[7] => Array
(
[ID] => 2686
[NAME] => Evgeny Shlyakhto
[DETAIL_PAGE_URL] => /experts/evgeniy-shlyakhto/
[POSITION] => Director General, Federal State Budgetary Institution National Medical Research Center named after V.A. Almazov, Ministry of Health of the Russian Federation
[DONOTLINK] =>
[PREVIEW_PICTURE] => 37035
)
[8] => Array
(
[ID] => 21859
[NAME] => Polina Stepensky
[DETAIL_PAGE_URL] => /experts/polina-stepensky/
[POSITION] => Head of Bone Marrow Transplantation & Cancer Immunotherapy of Adults and Children, Hadassah Medical Center in Israel
[DONOTLINK] =>
[PREVIEW_PICTURE] =>
)
[9] => Array
(
[ID] => 22232
[NAME] => Catherine Taylor
[DETAIL_PAGE_URL] => /experts/catherine-taylor/
[POSITION] => Director for Medical Affairs, Markets Evolution in EMEA region, Janssen
[DONOTLINK] =>
[PREVIEW_PICTURE] =>
)
[10] => Array
(
[ID] => 21857
[NAME] => Yuri Zhulev
[DETAIL_PAGE_URL] => /experts/yuri-zhulev/
[POSITION] => President, All-Russian Charitable Public Organization of Disabled People “Russian Hemophilia Society”
[DONOTLINK] =>
[PREVIEW_PICTURE] =>
)
)
[DESCRIPTION] => Array
(
[0] =>
[1] =>
[2] =>
[3] =>
[4] =>
[5] =>
[6] =>
[7] =>
[8] =>
[9] =>
[10] =>
)
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] => Array
(
[0] => 21853
[1] => 21854
[2] => 21851
[3] => 21856
[4] => 21858
[5] => 21860
[6] => 21861
[7] => 2686
[8] => 21859
[9] => 22232
[10] => 21857
)
[~DESCRIPTION] => Array
(
[0] =>
[1] =>
[2] =>
[3] =>
[4] =>
[5] =>
[6] =>
[7] =>
[8] =>
[9] =>
[10] =>
)
[~NAME] => Экперты
[~DEFAULT_VALUE] =>
)
[MEMBERS] => Array
(
[ID] => 69
[TIMESTAMP_X] => 2017-12-20 14:18:19
[IBLOCK_ID] => 18
[NAME] => Участники
[ACTIVE] => Y
[SORT] => 70
[CODE] => MEMBERS
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => E
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => Y
[XML_ID] =>
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 17
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Участники
[~DEFAULT_VALUE] =>
)
[MEMBERS_AND_EXPERTS] => Array
(
[ID] => 72
[TIMESTAMP_X] => 2017-12-20 14:18:13
[IBLOCK_ID] => 18
[NAME] => Участники и эксперты
[ACTIVE] => Y
[SORT] => 80
[CODE] => MEMBERS_AND_EXPERTS
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => E
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => Y
[XML_ID] =>
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 17
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Участники и эксперты
[~DEFAULT_VALUE] =>
)
[KEYREPORT_MODERATOR] => Array
(
[ID] => 115
[TIMESTAMP_X] => 2017-12-20 14:18:28
[IBLOCK_ID] => 18
[NAME] => Ключевой доклад/модератор
[ACTIVE] => Y
[SORT] => 90
[CODE] => KEYREPORT_MODERATOR
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => E
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => Y
[XML_ID] =>
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 0
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Ключевой доклад/модератор
[~DEFAULT_VALUE] =>
)
[SAY_HIS] => Array
(
[ID] => 246
[TIMESTAMP_X] => 2018-01-15 23:30:57
[IBLOCK_ID] => 18
[NAME] => Приветствие
[ACTIVE] => Y
[SORT] => 91
[CODE] => SAY_HIS
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => E
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => Y
[XML_ID] =>
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 17
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Приветствие
[~DEFAULT_VALUE] =>
)
[SPEECH] => Array
(
[ID] => 134
[TIMESTAMP_X] => 2017-12-20 14:18:48
[IBLOCK_ID] => 18
[NAME] => Выступления
[ACTIVE] => Y
[SORT] => 100
[CODE] => SPEECH
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => E
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => Y
[XML_ID] =>
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 0
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Выступления
[~DEFAULT_VALUE] =>
)
[DISCUSS_MEMBERS] => Array
(
[ID] => 226
[TIMESTAMP_X] => 2017-12-20 14:36:04
[IBLOCK_ID] => 18
[NAME] => Участники дискуссии
[ACTIVE] => Y
[SORT] => 101
[CODE] => DISCUSS_MEMBERS
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => E
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => Y
[XML_ID] =>
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 0
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Участники дискуссии
[~DEFAULT_VALUE] =>
)
[AUTHORS] => Array
(
[ID] => 227
[TIMESTAMP_X] => 2017-12-20 14:37:12
[IBLOCK_ID] => 18
[NAME] => Авторы
[ACTIVE] => Y
[SORT] => 102
[CODE] => AUTHORS
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => E
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => Y
[XML_ID] =>
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 17
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Авторы
[~DEFAULT_VALUE] =>
)
[LECTORS] => Array
(
[ID] => 228
[TIMESTAMP_X] => 2017-12-20 14:38:09
[IBLOCK_ID] => 18
[NAME] => Лекторы
[ACTIVE] => Y
[SORT] => 103
[CODE] => LECTORS
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => E
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => Y
[XML_ID] =>
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 8
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Лекторы
[~DEFAULT_VALUE] =>
)
[PRESENTATIONS] => Array
(
[ID] => 229
[TIMESTAMP_X] => 2017-12-20 14:38:40
[IBLOCK_ID] => 18
[NAME] => Презентация
[ACTIVE] => Y
[SORT] => 104
[CODE] => PRESENTATIONS
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => E
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => Y
[XML_ID] =>
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 17
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Презентация
[~DEFAULT_VALUE] =>
)
[SPEAKERS] => Array
(
[ID] => 230
[TIMESTAMP_X] => 2017-12-22 11:26:55
[IBLOCK_ID] => 18
[NAME] => Спикеры
[ACTIVE] => Y
[SORT] => 105
[CODE] => SPEAKERS
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => E
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => Y
[XML_ID] =>
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 17
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Спикеры
[~DEFAULT_VALUE] =>
)
[SUBTITLE] => Array
(
[ID] => 74
[TIMESTAMP_X] => 2017-12-20 14:19:10
[IBLOCK_ID] => 18
[NAME] => Подзаголовок
[ACTIVE] => Y
[SORT] => 110
[CODE] => SUBTITLE
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => S
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => N
[XML_ID] =>
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 0
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] => 120626
[VALUE] => Effective Healthcare
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] => Effective Healthcare
[~DESCRIPTION] =>
[~NAME] => Подзаголовок
[~DEFAULT_VALUE] =>
)
[MSP_REPRESENTATIVES] => Array
(
[ID] => 78
[TIMESTAMP_X] => 2017-12-20 14:20:11
[IBLOCK_ID] => 18
[NAME] => Представители МСП
[ACTIVE] => Y
[SORT] => 120
[CODE] => MSP_REPRESENTATIVES
[DEFAULT_VALUE] => Array
(
[TEXT] =>
[TYPE] => HTML
)
[PROPERTY_TYPE] => S
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => N
[XML_ID] =>
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 0
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] => HTML
[USER_TYPE_SETTINGS] => Array
(
[height] => 200
)
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Представители МСП
[~DEFAULT_VALUE] => Array
(
[TEXT] =>
[TYPE] => HTML
)
)
[MEDIA_LINK] => Array
(
[ID] => 135
[TIMESTAMP_X] => 2018-01-16 21:02:27
[IBLOCK_ID] => 18
[NAME] => Медиаматериалы
[ACTIVE] => Y
[SORT] => 130
[CODE] => MEDIA_LINK
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => E
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => N
[XML_ID] =>
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 36
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] => 139654
[VALUE] => 24375
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] => 24375
[~DESCRIPTION] =>
[~NAME] => Медиаматериалы
[~DEFAULT_VALUE] =>
)
[CALENDAR] => Array
(
[ID] => 131
[TIMESTAMP_X] => 2017-12-20 14:20:36
[IBLOCK_ID] => 18
[NAME] => Календарь
[ACTIVE] => Y
[SORT] => 140
[CODE] => CALENDAR
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => L
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => C
[MULTIPLE] => N
[XML_ID] =>
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 0
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[VALUE_ENUM_ID] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Календарь
[~DEFAULT_VALUE] =>
)
[EVENT_INFO] => Array
(
[ID] => 132
[TIMESTAMP_X] => 2017-12-20 14:20:36
[IBLOCK_ID] => 18
[NAME] => Информационное событие
[ACTIVE] => Y
[SORT] => 150
[CODE] => EVENT_INFO
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => L
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => C
[MULTIPLE] => N
[XML_ID] =>
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 0
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[VALUE_ENUM_ID] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Информационное событие
[~DEFAULT_VALUE] =>
)
[CHANGE] => Array
(
[ID] => 133
[TIMESTAMP_X] => 2017-12-20 14:20:36
[IBLOCK_ID] => 18
[NAME] => Изменение
[ACTIVE] => Y
[SORT] => 160
[CODE] => CHANGE
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => L
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => C
[MULTIPLE] => N
[XML_ID] =>
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 0
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[VALUE_ENUM_ID] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Изменение
[~DEFAULT_VALUE] =>
)
[LANGUAGES] => Array
(
[ID] => 224
[TIMESTAMP_X] => 2017-12-20 14:26:52
[IBLOCK_ID] => 18
[NAME] => Рабочие языки
[ACTIVE] => Y
[SORT] => 170
[CODE] => LANGUAGES
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => L
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => C
[MULTIPLE] => Y
[XML_ID] =>
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 0
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] => Array
(
[0] => 139656
[1] => 139655
)
[VALUE] => Array
(
[0] => Russian
[1] => English
)
[DESCRIPTION] => Array
(
[0] =>
[1] =>
)
[VALUE_ENUM] => Array
(
[0] => Russian
[1] => English
)
[VALUE_XML_ID] => Array
(
[0] => affb1430ade1dabb9b750ff1961d2505
[1] => 296b3d354b8509e4ce2133793442286c
)
[VALUE_SORT] => Array
(
[0] => 10
[1] => 30
)
[VALUE_ENUM_ID] => Array
(
[0] => 54
[1] => 56
)
[~VALUE] => Array
(
[0] => Russian
[1] => English
)
[~DESCRIPTION] => Array
(
[0] =>
[1] =>
)
[~NAME] => Рабочие языки
[~DEFAULT_VALUE] =>
)
[INVITATION_ONLY] => Array
(
[ID] => 225
[TIMESTAMP_X] => 2017-12-22 18:34:07
[IBLOCK_ID] => 18
[NAME] => Вход по индивидуальным приглашениям
[ACTIVE] => Y
[SORT] => 180
[CODE] => INVITATION_ONLY
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => L
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => C
[MULTIPLE] => N
[XML_ID] =>
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 0
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[VALUE_ENUM_ID] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Вход по индивидуальным приглашениям
[~DEFAULT_VALUE] =>
)
[PREMIUM_ONLY] => Array
(
[ID] => 233
[TIMESTAMP_X] => 2017-12-22 18:34:07
[IBLOCK_ID] => 18
[NAME] => Вход с бэйджами категории «ПРЕМИУМ»
[ACTIVE] => Y
[SORT] => 190
[CODE] => PREMIUM_ONLY
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => L
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => C
[MULTIPLE] => N
[XML_ID] =>
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 0
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[VALUE_ENUM_ID] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Вход с бэйджами категории «ПРЕМИУМ»
[~DEFAULT_VALUE] =>
)
[KEYNOTE_FILE] => Array
(
[ID] => 239
[TIMESTAMP_X] => 2019-01-14 21:47:41
[IBLOCK_ID] => 18
[NAME] => Доклад
[ACTIVE] => Y
[SORT] => 200
[CODE] => KEYNOTE_FILE
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => F
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => Y
[XML_ID] =>
[FILE_TYPE] => pdf
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 0
[WITH_DESCRIPTION] => Y
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Доклад
[~DEFAULT_VALUE] =>
)
[OPENINGS] => Array
(
[ID] => 241
[TIMESTAMP_X] => 2018-01-05 18:10:45
[IBLOCK_ID] => 18
[NAME] => Открытие
[ACTIVE] => Y
[SORT] => 500
[CODE] => OPENINGS
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => E
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => Y
[XML_ID] =>
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 17
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Открытие
[~DEFAULT_VALUE] =>
)
[EVENT_CATEGORY] => Array
(
[ID] => 298
[TIMESTAMP_X] => 2019-12-27 11:18:04
[IBLOCK_ID] => 18
[NAME] => Категория мероприятия
[ACTIVE] => Y
[SORT] => 500
[CODE] => EVENT_CATEGORY
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => L
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => N
[XML_ID] =>
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 0
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] => 139658
[VALUE] => Scientific Expert Program
[DESCRIPTION] =>
[VALUE_ENUM] => Scientific Expert Program
[VALUE_XML_ID] => #7fa6cb,#333333
[VALUE_SORT] => 200
[VALUE_ENUM_ID] => 97
[~VALUE] => Scientific Expert Program
[~DESCRIPTION] =>
[~NAME] => Категория мероприятия
[~DEFAULT_VALUE] =>
)
[KEYREPORT2S] => Array
(
[ID] => 306
[TIMESTAMP_X] => 2019-12-31 10:17:49
[IBLOCK_ID] => 18
[NAME] => Ключевые выступления
[ACTIVE] => Y
[SORT] => 500
[CODE] => KEYREPORT2S
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => E
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => Y
[XML_ID] =>
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 17
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Ключевые выступления
[~DEFAULT_VALUE] =>
)
)
[DISPLAY_PROPERTIES] => Array
(
[QUESTIONS] => Array
(
[ID] => 50
[TIMESTAMP_X] => 2017-12-20 14:14:00
[IBLOCK_ID] => 18
[NAME] => Вопросы для обсуждения
[ACTIVE] => Y
[SORT] => 10
[CODE] => QUESTIONS
[DEFAULT_VALUE] => Array
(
[TYPE] => HTML
[TEXT] =>
)
[PROPERTY_TYPE] => S
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => N
[XML_ID] => 12
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 0
[WITH_DESCRIPTION] => Y
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] => HTML
[USER_TYPE_SETTINGS] => Array
(
[height] => 200
)
[HINT] =>
[PROPERTY_VALUE_ID] => 120621
[VALUE] => Array
(
[TEXT] => <p>
</p>
<ul class="style-prog-list">
<li>Biomedical cell products and high-tech medicines: harmonization of concepts within a single pharmaceutical market framework. </li>
<li>
Providing government funding to use gene technologies in the healthcare system.</li>
</ul>
[TYPE] => HTML
)
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] => Array
(
[TEXT] =>
Biomedical cell products and high-tech medicines: harmonization of concepts within a single pharmaceutical market framework.
Providing government funding to use gene technologies in the healthcare system.
[TYPE] => HTML
)
[~DESCRIPTION] =>
[~NAME] => Вопросы для обсуждения
[~DEFAULT_VALUE] => Array
(
[TYPE] => HTML
[TEXT] =>
)
[DISPLAY_VALUE] =>
Biomedical cell products and high-tech medicines: harmonization of concepts within a single pharmaceutical market framework.
Providing government funding to use gene technologies in the healthcare system.
The world is rapidly developing genetic, cellular and genomic technologies in healthcare, including the rigorous introduction of gene therapy and cellular drugs into clinical practice to target the cause of the disease. The emergence of this class of drugs has made it possible to effectively combat diseases that used to be incurable.
The introduction and application of innovative gene therapy and cell technologies in Russia is difficult for a number of reasons: a complicated registration process, patients' limited access to genetic diagnostic methods, and an imperfect medical care payment system. Successful implementation of innovative technologies is possible only with an intensive dialogue between the state and the manufacturers in order to adapt legal regulation and ensure better availability of such technologies for patients.
